GeneDx Holdings Corp (NASDAQ:WGS) has a beta value of 2.00 and has seen 1.01 million shares traded in the last trading session. The company, currently valued at $2.45B, closed the last trade at $87.17 per share which meant it lost -$2.49 on the day or -2.78% during that session. The WGS stock price is -32.61% off its 52-week high price of $115.60 and 91.14% above the 52-week low of $7.72.
The consensus among analysts is that GeneDx Holdings Corp (WGS) is Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.11.
GeneDx Holdings Corp (NASDAQ:WGS) trade information
Sporting -2.78% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the WGS stock price touched $87.17 or saw a rise of 17.51%. Year-to-date, GeneDx Holdings Corp shares have moved 13.41%, while the 5-day performance has seen it change -11.95%. Over the past 30 days, the shares of GeneDx Holdings Corp (NASDAQ:WGS) have changed 46.41%.
Wall Street analysts have a consensus price target for the stock at $70, which means that the shares’ value could drop -24.53% from current levels. The projected low price target is $70.0 while the price target rests at a high of $70.0. In that case, then, we find that the current price level is 19.7% off the targeted high while a plunge would see the stock lose 19.7% from current levels.
GeneDx Holdings Corp (WGS) estimates and forecasts
The company’s shares have gained 164.23% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 17.40%.
6 analysts offering their estimates for the company have set an average revenue estimate of 79.9M for the current quarter. 6 have an estimated revenue figure of 85.32M for the next ending quarter. Year-ago sales stood 62.42M and 70.51M respectively for this quarter and the next, and analysts expect sales will grow by 27.99% for the current quarter and 17.40% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 96.65% over the past 5 years. Earnings growth for 2025 is a modest 248.68% while over the next 5 years, the company’s earnings are expected to increase by 119.03%.
WGS Dividends
GeneDx Holdings Corp is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
GeneDx Holdings Corp (NASDAQ:WGS)’s Major holders
The top two institutional holders are CASDIN CAPITAL, LLC with over 3.53 million shares worth more than $92.18 million. As of 2024-06-30, CASDIN CAPITAL, LLC held 13.2482% of shares outstanding.
The other major institutional holder is CORVEX MANAGEMENT LP, with the holding of over 2.47 million shares as of 2024-06-30. The firm’s total holdings are worth over $64.66 million and represent 9.2937% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Alger Small Cap Focus Fund . As of Dec 31, 2024 , the former fund manager holds about 1.86% shares in the company for having 521.12 shares of worth $45.43 million while later fund manager owns 461.76 shares of worth $40.25 million as of Oct 31, 2024 , which makes it owner of about 1.65% of company’s outstanding stock.
